- News Home
17 April 2014 12:48 pm ,
Vol. 344 ,
Officials last week revealed that the U.S. contribution to ITER could cost $3.9 billion by 2034—roughly four times the...
An experimental hepatitis B drug that looked safe in animal trials tragically killed five of 15 patients in 1993. Now,...
Using the two high-quality genomes that exist for Neandertals and Denisovans, researchers find clues to gene activity...
A new report from the Intergovernmental Panel on Climate Change (IPCC) concludes that humanity has done little to slow...
Astronomers have discovered an Earth-sized planet in the habitable zone of a red dwarf—a star cooler than the sun—500...
Three years ago, Jennifer Francis of Rutgers University proposed that a warming Arctic was altering the behavior of the...
- 17 April 2014 12:48 pm , Vol. 344 , #6181
- About Us
90 Papers by German Could Be Retracted on Ethics Concerns
4 February 2011 2:11 pm
An ongoing investigation into the work of a German anaesthesiologist may lead to as many as 90 retractions. Joachim Boldt was fired in November from his job as head of anesthesia at the Klinikum Ludwigshafen after an investigation into a 2009 paper raised suspicions that the study described in the article had never taken place. Boldt has published more than 300 articles, many about the safety of a type of fluid replacement used during surgery called hydroxyethyl starch . Retraction Watch has been following the story in detail.
Today, the Klinikum Ludwigshafen and the German state medical association of Rheinland Pfalz announced that 90 of 115 studies they examined lacked proper approval from an institutional review board (IRB).
That prompted a joint letter from the editors of 11 journals stating that lack of IRB approval is grounds for automatic retraction of an article. The editor of Anaesthesia & Analgesia, where the 2009 paper was published, also issued a statement, and the journal published four editorials about the case online.
The clinic's investigation is ongoing. They said in a statement today that there is no evidence that patients were harmed in any of the studies. Experts in Germany, however, are now recommending against routine use of hydroxyethyl starch given the questions surrounding Boldt's work.